These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 162259)

  • 1. Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.
    Selkoe DJ
    Trans Am Neurol Assoc; 1979; 104():70-4. PubMed ID: 162259
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 3. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
    Freeman W; Morton AJ
    Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
    Nemeroff CB; Bissette G
    Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease.
    MacGibbon GA; Lawlor PA; Walton M; Sirimanne E; Faull RL; Synek B; Mee E; Connor B; Dragunow M
    Exp Neurol; 1997 Oct; 147(2):316-32. PubMed ID: 9344557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin structure in dementia.
    McLachlan DR; Lewis PN; Lukiw WJ; Sima A; Bergeron C; De Boni U
    Ann Neurol; 1984 Apr; 15(4):329-34. PubMed ID: 6742779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer-related neuronal protein A68: specificity and distribution.
    Wolozin B; Davies P
    Ann Neurol; 1987 Oct; 22(4):521-6. PubMed ID: 3435070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemistry of dementia.
    Whitehouse PJ; Unnerstall JR
    Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
    Nordberg A; Alafuzoff I; Winblad B
    J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Approach to the dementia research].
    Tomonaga M
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1532-5. PubMed ID: 2698299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cognitive impairment in Alzheimer's disease and Huntington's disease.
    Brandt J; Folstein SE; Folstein MF
    Ann Neurol; 1988 Jun; 23(6):555-61. PubMed ID: 2970248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias.
    Rehman HU
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1637-42. PubMed ID: 12476966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the expression and phosphorylation of neurofilament proteins of brain gray matter in Alzheimer's disease].
    Wang YP; Wei ZL; Wang XC; Wang Q; Wang JZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):445-9. PubMed ID: 12905859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: human brain protein 13-7.
    Miner GD; Trapp GA; McSwigan J; Heston LL
    J Neurochem; 1976 Mar; 26(3):605-7. PubMed ID: 1262881
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.